GlaxoSmithKline names new president of global pharmaceuticals

GlaxoSmithKline has announced the appointment of Luke Miels as its new president for global pharmaceuticals.

The new hire comes after Abbas Hussain, who previously occupied this role, announced his decision to leave the company later this year, bringing to an end a successful GlaxoSmithKline career that dates back to 2008.

Under Mr Abbas' leadership, pharmaceutical and vaccine commercial performance for the company's US and European businesses has significantly improved, with a number of successful new product launches achieved.

His successor Mr Miels joins from AstraZeneca, where he currently serves as its executive vice-president for the European business. His start data with GlaxoSmithKline will be announced at a later date.

At GlaxoSmithKline, he will be responsible for a portfolio of medicines and vaccines with annual sales of more than 15 billion pounds and operations in over 100 markets.

Emma Walmsley, the incoming chief executive officer for GlaxoSmithKline, said: "Luke will bring a strong new voice to the decisions and choices we will have to make for our pharmaceuticals business. I am delighted he has agreed to join GlaxoSmithKline."

With over 20 years of experience within the pharmaceutical market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current pharmaceutical roles we have available, you can search for the latest job roles, register your details, or contact the team today.